1.Prof.Zheng Qinlong's team and the CNCL Group's"LANDSCAPE OF DRIVER MUTATIONS AND THEIR CLINICAL IMPACTS IN CHINESE PEDIATRIC PATIENTS.WITH MATURE B-CELL NON-HODGKIN'S LYMPHOMA AND T-CELL LYMPHOBLASTIC LYMPHOMA"was selected to give an oral speech at ICML2023.

2.Study of"ANALYSIS TREATMENT OUTCOME OF 46 REFRACTORY/RELAPSED PEDIATRIC MATURE B CELL LYMPHOMA"led by Professor Zhang Yonghong Analysis treatment outcome of 46 refractory/relapsed pediatric mature B cell lymphoma"PATIENTS-MULTI-CENTER EXPERIENCE FROM CHINA"was selected to give an oral speech at ICML2023.